State Obesity Advocacy Fact Sheets
The 50 states ranked by the Obesity Action Coalition (OAC) These sources are a collection of fact sheets from the Obesity Action Coalition (OAC), one for each of the fifty states and the District of Columbia, providing data on the impact of obesity, including state rankings, the percentage of adults classified as obese, overweight, and normal weight, and […]
New Obesity Drugs Defy Logic – And Succeed
Drugs that both activate and block the GIP receptor reduce weight through different brain mechanisms, offering a new direction for targeted obesity treatments. Drugs that target the receptors for the hormones GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) have proven effective in treating obesity and type 2 diabetes. While GLP-1 and GIP receptor agonists […]
News Article – WHO Leaning Toward Adding Obesity Drugs for Adults to Essential Medicines List: Reuters
May 2, 2025 According to the provided text from Fox News, the World Health Organization (WHO) is planning to endorse the use of GLP-1 weight-loss medications for adults as a strategy to combat the global obesity crisis. This support aims to improve access to these drugs, particularly in low- and middle-income countries, where a significant portion of the world’s obese population resides. The […]
Healthcare News – Cigna doubles down on GLP-1 support programs with 2 new launches
The company’s health services division Evernorth is unveiling new programs in a reliable growth area: assuaging payer concerns around GLP-1 coverage. Dive Brief: This article focuses on Cigna’s strategies regarding the growing demand for GLP-1 weight loss medications. Cigna’s health services division, Evernorth, is launching two new support programs aimed at assisting patients and easing concerns for payers regarding the high […]